journal article·2021-08

In Vivo Plain X‐Ray Imaging of Cancer Using Perovskite Quantum Dot Scintillators

Ilhwan Ryu, Jee‐Yeon Ryu, Geunpyo Choe, Hyemin Kwon, Hyeji Park, Young‐Seok Cho, Rose Du, Sanggyu Yim

Advanced Functional Materials· Volume 31· Issue 34
Publisher page

Abstract

Abstract Real‐time in vivo detection of cancer via attenuation‐based plain X‐ray imaging is proposed to fundamentally overcome the penetration depth limits of current fluorescence‐based imaging techniques. Using cesium lead bromide (CsPbBr3, CPB) quantum dot (QD) scintillators, real‐time X‐ray detection of 5 mm‐sized Panc‐1 cell tumors grown in a mouse is successfully performed. The QDs are rapidly co‐synthesized and double‐encapsulated with silicon dioxide (SiO2) to completely prevent them from being aggregated, decomposed, or released; they are then conjugated with antibodies to target pancreatic cancer. Due to the dramatic X‐ray attenuation, the X‐ray signal from the CPB QDs placed under the 2 cm‐thick tissue is clearly observed, while their fluorescence signal is not detected at all. In in vivo mouse experiments, the injection of a tiny amount (2.8 μg on a QD basis) of the CPB–SiO2@SiO2–Ab nanoparticles gives rise to a bright spot at the location of the tumor. Cell viability assay and histological analysis confirm the biocompatibility and nontoxicity of the nanoparticles.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Perovskite Materials and Applications · Luminescence Properties of Advanced Materials · Quantum Dots Synthesis And Properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry Kookmin University Seoul 02707 South Korea

Department of Neurosurgery Brigham and Women's Hospital Harvard Medical School Boston MA 02115 USA

Division of Gastroenterology Department of Internal Medicine The Catholic University of Korea Seoul 06591 South Korea

Funding

National Research Foundation of Korea

References (39)

Show source-provided references
1. 10.3322/caac.2159010.3322/caac.21590 ↗
2. 10.1038/bjc.2015.4910.1038/bjc.2015.49 ↗
3. 10.1089/cbr.2017.237810.1089/cbr.2017.2378 ↗
4. 10.1126/science.112594910.1126/science.1125949 ↗
5. 10.1038/s41598-019-39502-w10.1038/s41598-019-39502-w ↗
6. Davis M. E. · Nat. Rev. Drug Discovery · 2009 · 7 · 239
7. 10.1002/adma.20170635610.1002/adma.201706356 ↗
8. 10.1053/j.semnuclmed.2006.03.00510.1053/j.semnuclmed.2006.03.005 ↗
9. 10.1021/acs.chemrev.5b0014810.1021/acs.chemrev.5b00148 ↗
10. 10.1073/pnas.150852411210.1073/pnas.1508524112 ↗
11. 10.1038/s41551-017-0131-810.1038/s41551-017-0131-8 ↗
12. 10.1117/1.JBO.21.12.12600610.1117/1.JBO.21.12.126006 ↗
13. 10.1038/nphoton.2014.16610.1038/nphoton.2014.166 ↗
14. 10.1039/C8SC01153B10.1039/C8SC01153B ↗
15. 10.1021/acs.chemrev.5b0000810.1021/acs.chemrev.5b00008 ↗
16. 10.1098/rsta.2011.026410.1098/rsta.2011.0264 ↗
17. 10.1038/nature2475510.1038/nature24755 ↗
18. 10.1039/C6CS00616G10.1039/C6CS00616G ↗
19. 10.1158/0008-5472.CAN-13-238710.1158/0008-5472.CAN-13-2387 ↗
20. 10.1016/j.mayocp.2015.07.01110.1016/j.mayocp.2015.07.011 ↗
21. 10.1038/s41586-018-0451-110.1038/s41586-018-0451-1 ↗
22. 10.1038/s41598-017-08843-910.1038/s41598-017-08843-9 ↗
23. 10.1021/acs.chemrev.8b0064410.1021/acs.chemrev.8b00644 ↗
24. 10.1039/C8CS00740C10.1039/C8CS00740C ↗
25. 10.1021/acs.chemmater.7b0047810.1021/acs.chemmater.7b00478 ↗
26. 10.1038/am.2016.16710.1038/am.2016.167 ↗
27. 10.1021/acsnano.6b0761710.1021/acsnano.6b07617 ↗
28. 10.1364/PRJ.39984510.1364/PRJ.399845 ↗
29. 2012 Centers for Disease Control and Prevention Atlanta GA
30. J. H. Hubbell S. M. Seltzer 2004 U.S. Secretary of Commerce Washington DC
31. Allisy‐Roberts P. · 2007
32. Smith S. W. · 1997
33. Li X. ‐P. · Int. J. Clin. Exp. Pathol. · 2015 · 8 · 6724
34. 10.1002/1520-6866(2001)21:1<97::AID-TCM9>3.0.CO;2-O10.1002/1520-6866(2001)21:1<97::AID-TCM9>3.0.CO;2-O ↗
35. 10.1182/blood-2002-10-322910.1182/blood-2002-10-3229 ↗
36. 10.1016/j.ab.2011.05.01810.1016/j.ab.2011.05.018 ↗
37. 10.1038/ncomms1014910.1038/ncomms10149 ↗
38. 10.1080/1537651070166581410.1080/15376510701665814 ↗
39. 10.3390/ijerph705200810.3390/ijerph7052008 ↗